Moderna names former PerkinElmer exec as new CFO
Reuters
Published Aug 17, 2022 08:19AM ET
Updated Aug 17, 2022 08:40AM ET
(Reuters) - Moderna (NASDAQ:MRNA) Inc on Wednesday named former PerkinElmer (NYSE:PKI) executive James Mock as its new finance chief, months after the abrupt exit of former CFO Jorge Gomez.
The COVID-19 vaccine maker had appointed Dentsply Sirona's Gomez as finance chief in April, but he left his position a day after taking charge the next month.
Gomez's departure followed an investigation launched by his former employer, Moderna said.
Following the exit, former Moderna CFO David Meline returned from his recent retirement to take over the role.
Moderna on Wednesday said Mock would start as finance chief from Sept. 6. Meline would retire on the same day but shall remain as a consultant through the transition.
Before joining Moderna, Mock was the chief financial officer of PerkinElmer, a life sciences and diagnostics company.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.